Euda Health Holdings Limited (NASDAQ:EUDA)
| Market Cap | 30.22M-23.7% |
| Revenue (ttm) | 11.76M+193.2% |
| Net Income | -4.76M+69.0% |
| EPS | -2.56+79.5% |
| Shares Out | 1.87M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 74,632.998 |
| Open | 14.29 |
| Previous Close | 13.45 |
| Day's Range | 14.29 - 18.66 |
| 52-Week Range | 5.26 - 86.00 |
| Beta | 0.59 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Mar 3, 2027 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About EUDA
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.
$EUDA stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in EUDA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by EUDA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
EUDA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
EUDA Revenue by Segment or Geography
As of: Q1 2023 (Mar 31, 2023) · Source: SEC EDGAR (10-Q)
U.S. Patents
New EUDA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to EUDA from public contracts
Source: USAspending.gov
EUDA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from EUDA’s recent data — informational, not investment advice